Plasminogen decreases Aβ42 and Tau deposition, and shows multi-beneficial effects on Alzheimer's disease in mice and humans
出版年份 2023 全文链接
标题
Plasminogen decreases Aβ42 and Tau deposition, and shows multi-beneficial effects on Alzheimer's disease in mice and humans
作者
关键词
-
出版物
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 654, Issue -, Pages 102-111
出版商
Elsevier BV
发表日期
2023-03-01
DOI
10.1016/j.bbrc.2023.02.078
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Resurrecting the Mysteries of Big Tau
- (2020) Itzhak Fischer et al. TRENDS IN NEUROSCIENCES
- High-Fat Diet Enhances Working Memory in the Y-Maze Test in Male C57BL/6J Mice with Less Anxiety in the Elevated Plus Maze Test
- (2020) Kaichi Yoshizaki et al. Nutrients
- Site-specific PEGylation of micro-plasmin for improved thrombolytic therapy through engineering enhanced resistance against serpin mediated inhibition
- (2019) Navneet Kaur et al. PLoS One
- Novel Peptidomic Approach for Identification of Low and High Molecular Weight Tauopathy Peptides Following Calpain Digestion, and Primary Culture Neurotoxic Challenges
- (2019) Hamad Yadikar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Alzheimer’s disease paper 1: clinical update on epidemiology, pathophysiology and diagnosis
- (2018) Dhamidhu Eratne et al. Australasian Psychiatry
- A molecular approach in drug development for Alzheimer’s disease
- (2018) Snezana Agatonovic-Kustrin et al. BIOMEDICINE & PHARMACOTHERAPY
- Sex-biased hippocampal pathology in the 5XFAD mouse model of Alzheimer's disease: A multi-omic analysis
- (2018) Joseph L. Bundy et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Tau-imaging in neurodegeneration
- (2017) Gérard N. Bischof et al. METHODS
- Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24-week, Randomized, Double-Blind Parallel-Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily)
- (2016) Zhen-Xin Zhang et al. CNS Neuroscience & Therapeutics
- Alzheimer's disease: Targeting the Cholinergic System
- (2016) Talita H. Ferreira-Vieira et al. Current Neuropharmacology
- Tissue-Plasminogen Activator Attenuates Alzheimer’s Disease-Related Pathology Development in APPswe/PS1 Mice
- (2015) Ayman ElAli et al. NEUROPSYCHOPHARMACOLOGY
- Structure and function of plasminogen/plasmin system
- (2014) R. B. Aisina et al. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY
- GDNF, NGF and BDNF as therapeutic options for neurodegeneration
- (2013) Shelley J. Allen et al. PHARMACOLOGY & THERAPEUTICS
- Plasminogen is a key proinflammatory regulator that accelerates the healing of acute and diabetic wounds
- (2012) Y. Shen et al. BLOOD
- Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial
- (2012) Chris Fox et al. PLoS One
- High-molecular weight Aβ oligomers and protofibrils are the predominant Aβ species in the native soluble protein fraction of the AD brain
- (2011) Ajeet Rijal Upadhaya et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- APP processing in Alzheimer's disease
- (2011) Yun-wu Zhang et al. Molecular Brain
- Plasminogen and plasmin in Alzheimer's disease
- (2010) Rachel Barker et al. BRAIN RESEARCH
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease
- (2010) Sadim Jawhar et al. NEUROBIOLOGY OF AGING
- Activation of pro-BDNF by the pericellular serine protease plasmin
- (2008) Kelly Gray et al. FEBS LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started